EirGenix Inc. (TPE:6589)
Taiwan
· Delayed Price · Currency is TWD 57.00
-2.80 (-4.68%)
At close: Mar 9, 2026
EirGenix Revenue
EirGenix had revenue of 229.00M TWD in the quarter ending September 30, 2025, a decrease of -7.74%. This brings the company's revenue in the last twelve months to 936.18M, down -20.05% year-over-year. In the year 2024, EirGenix had annual revenue of 1.01B, down -1.34%.
Revenue (ttm)
936.18M
Revenue Growth
-20.05%
P/S Ratio
18.42
Revenue / Employee
936.18K
Employees
1,000
Market Cap
17.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.01B | -13.69M | -1.34% |
| Dec 31, 2023 | 1.02B | -458.36M | -30.95% |
| Dec 31, 2022 | 1.48B | -216.34M | -12.75% |
| Dec 31, 2021 | 1.70B | 625.52M | 58.36% |
| Dec 31, 2020 | 1.07B | 595.75M | 125.14% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sunmax Biotechnology | 2.00B |
| TaiMed Biologics | 607.22M |
| AP Biosciences | 32.25M |
| TCM Biotech International | 682.40M |
| Polaris Group | 70.83M |
| Ever Supreme Bio Technology | 1.01B |
| Oneness Biotech | 117.33M |
| Lumosa Therapeutics | 35.83M |